Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-18T07:07:54.347Z Has data issue: false hasContentIssue false

Relationship of Lutein and Zeaxanthin Levels to Neurocognitive Functioning: An fMRI Study of Older Adults

Published online by Cambridge University Press:  25 October 2016

Cutter A. Lindbergh
Affiliation:
Department of Psychology, University of Georgia, Athens, Georgia
Catherine M. Mewborn
Affiliation:
Department of Psychology, University of Georgia, Athens, Georgia
Billy R. Hammond
Affiliation:
Department of Psychology, University of Georgia, Athens, Georgia
Lisa M. Renzi-Hammond
Affiliation:
Department of Psychology, University of Georgia, Athens, Georgia
Joanne M. Curran-Celentano
Affiliation:
Department of Molecular, Cellular, and Biomedical Sciences, University of New Hampshire, Kendall Hall, Durham, New Hampshire
L. Stephen Miller*
Affiliation:
Department of Psychology, University of Georgia, Athens, Georgia Bio-Imaging Research Center, Paul D. Coverdell Center, University of Georgia, Athens, Georgia
*
Correspondence and reprint requests to: L. Stephen Miller, Department of Psychology, Psychology Building, University of Georgia, Athens, Georgia 30602. E-mail: lsmiller@uga.edu
Rights & Permissions [Opens in a new window]

Abstract

Objectives: It is well known that the carotenoids lutein (L) and zeaxanthin (Z) improve eye health and an accumulating evidence base suggests cognitive benefits as well. The present study investigated underlying neural mechanisms using functional magnetic resonance imaging (fMRI). It was hypothesized that lower L and Z concentrations would be associated with neurobiological inefficiency (i.e., increased activation) during cognitive performance. Methods: Forty-three community-dwelling older adults (mean age=72 years; 58% female; 100% Caucasian) were asked to learn and recall pairs of unrelated words in an fMRI-adapted paradigm. L and Z levels were measured in retina (macular pigment optical density) and serum using validated procedures. Results: Following first-level contrasts of encoding and retrieval trials minus control trials (p<.05, family-wise error corrected, minimum voxel cluster=8), L and Z were found to significantly and negatively relate to blood-oxygen-level-dependent signal in central and parietal operculum cortex, inferior frontal gyrus, supramarginal gyrus, planum polare, frontal and middle temporal gyrus, superior parietal lobule, postcentral gyrus, precentral gyrus, occipital cortex bilaterally, and cerebellar regions. Conclusions: To the authors’ knowledge, the present study represents the first attempt to investigate neural mechanisms underlying the relation of L and Z to cognition using fMRI. The observed results suggest that L and Z promote cognitive functioning in old age by enhancing neural efficiency. (JINS, 2017, 23, 11–22)

Type
Research Articles
Copyright
Copyright © The International Neuropsychological Society 2016 

INTRODUCTION

The xanthophylls lutein (L) and zeaxanthin (Z) are among 600 naturally occurring carotenoids that must be acquired via diet, predominantly through consumption of green leafy vegetables and colored fruits. Of the 30–40 carotenoids present in human sera, generally speaking, only L and Z cross the blood–retina barrier to form macular pigment (Bone, Landrum, & Tarsis, Reference Bone, Landrum and Tarsis1985). L and Z also preferentially accumulate in brain tissue, including frontal, occipital, and temporal cortices, as well as the cerebellum and pons, accounting for 66–77% of total brain carotenoid levels (Craft, Haitema, Garnett, Fitch, & Dorey, Reference Craft, Haitema, Garnett, Fitch and Dorey2004; Johnson et al., Reference Johnson, Vishwanathan, Johnson, Hausman, Davey, Scott and Poon2013; Vishwanathan, Kuchan, Sen, & Johnson, Reference Vishwanathan, Kuchan, Sen and Johnson2014). As isomers with identical chemical compositions and extremely similar structures (Krinsky, 2002), L and Z are often administered together in clinical trials (e.g., Chew et al., Reference Chew, Clemons, SanGiovanni, Danis, Ferris, Elman and Fish2014) and their effects are routinely considered conjointly in analyses (e.g., Vishwanathan, Iannaccone, et al., Reference Vishwanathan, Iannaccone, Scott, Kritchevsky, Jennings, Carboni and Johnson2014).

L and Z have demonstrated potential to benefit a range of neurodegenerative disorders, such as age-related macular degeneration, diabetic retinopathy, dementia, and Huntington’s disease (Arnal, Miranda, Barcia, Bosch-Morell, & Romero, Reference Arnal, Miranda, Barcia, Bosch-Morell and Romero2010; Binawade & Jagtap, Reference Binawade and Jagtap2013; Chew et al., Reference Chew, Clemons, SanGiovanni, Danis, Ferris, Elman and Fish2014; Feart et al., Reference Feart, Letenneur, Helmer, Samieri, Schalch, Etheve and Barberger-Gateau2016; Scanlon et al., Reference Scanlon, Connell, Ratzlaff, Foerg, McCartney, Murphy and Loughman2015; Wang, Shinto, Connor, & Quinn, Reference Wang, Shinto, Connor and Quinn2008). Results also appear to support a role of the macular carotenoids, not only in reducing the probability of age-related disease, but also in preventing many of the changes that tend to precede those diseases. For instance, preliminary data suggest a connection between L and Z levels, measured in serum and in retina, and executive cognitive functions, verbal fluency, attention, logical reasoning, psychomotor speed, perceptual speed, learning, memory, language, visual-spatial and constructional abilities, and global cognition (Akbaraly, Faure, Gourlet, Favier, & Beer, Reference Akbaraly, Faure, Gourlet, Favier and Berr2007; Feeney et al., Reference Feeney, Finucane, Savva, Cronin, Beatty, Nolan and Kenny2013; Renzi, Dengler, Puente, Miller, & Hammond, Reference Renzi, Dengler, Puente, Miller and Hammond2014; Vishwanathan, Iannaccone, et al., Reference Vishwanathan, Iannaccone, Scott, Kritchevsky, Jennings, Carboni and Johnson2014).

Dietary intake of green leafy vegetables high in L and Z buffers older adults from global cognitive decline, as demonstrated in longitudinal designs (Kang, Ascherio, & Grodstein, Reference Kang, Ascherio and Grodstein2005; Morris, Evans, Tangney, Bienias, & Wilson, Reference Morris, Evans, Tangney, Bienias and Wilson2006). Although most of the relevant data is cross-sectional, in an exploratory intervention trial in older women, docosahexaenoic acid and L supplementation were associated with improvements in verbal fluency, memory, and learning slope when compared to placebo (Johnson et al., 2008; although, see Chew et al., Reference Chew, Clemons, Agrón, Launer, Grodstein and Bernstein2015). Taken together, there is promising evidence suggesting that L and Z exert a positive effect on a range of cognitive outcomes in older adults.

L and Z have traditionally been measured via two primary methods: serum and retinal levels. Serum levels of L and Z, which are frequently combined for analyses due to their chemical and structural correspondence (e.g., Bone, Landrum, Dixon, Chen, & Llerena, Reference Bone, Landrum, Dixon, Chen and Llerena2000; Olmedilla-Alonso, Beltran-de-Miguel, Estevez-Santiago, & Cuadrado-Vives, Reference Olmedilla-Alonso, Beltrán-de-Miguel, Estévez-Santiago and Cuadrado-Vives2014; Vishwanathan, Iannaccone, et al., Reference Vishwanathan, Iannaccone, Scott, Kritchevsky, Jennings, Carboni and Johnson2014), are driven by recent dietary intakes and do not necessarily reflect long-term dietary behavior, unless dietary behavior is stable in the individuals measured (Beatty, Nolan, Kavanagh, & O’Donovan, Reference Beatty, Nolan, Kavanagh and O’Donovan2004). Some studies have found that serum L and Z levels remain generally constant with advancing age (e.g., Cardinault et al., Reference Cardinault, Gorrand, Tyssandier, Grolier, Rock and Borel2003) while others have observed modest increases (e.g., Olmedilla-Alonso et al., Reference Olmedilla-Alonso, Beltrán-de-Miguel, Estévez-Santiago and Cuadrado-Vives2014) likely related to corresponding increases in dietary intake (Johnson, Maras, Rasmussen, & Tucker, Reference Johnson, Maras, Rasmussen and Tucker2010). However, serum L and Z is lower in individuals with mild cognitive impairment and Alzheimer’s disease compared to cognitively healthy individuals (Nolan et al., Reference Nolan, Loskutova, Howard, Moran, Mulcahy, Stack and Beatty2014; Rinaldi et al., Reference Rinaldi, Polidori, Metastasio, Mariani, Mattioli, Cherubini and Mecocci2003). In the retina, L and Z preferentially accumulate in the macula as macular pigment (MP), and optical density of the macular pigment layer (MPOD) can be measured non-invasively using psychophysical techniques. The most common method of measuring MPOD, heterochromatic flicker photometry, has been well-validated (Hammond, Wooten, & Smollon, Reference Hammond, Wooten and Smollon2005) and may serve as a biomarker of L and Z concentrations in brain tissue (e.g., Vishwanathan, Iannaccone, et al., Reference Vishwanathan, Iannaccone, Scott, Kritchevsky, Jennings, Carboni and Johnson2014; Vishwanathan, Neuringer, Snodderly, Schalch, & Johnson, Reference Vishwanathan, Neuringer, Snodderly, Schalch and Johnson2013). Like serum levels, MPOD appears to be lower in individuals with cognitive impairment and dementia (Feeney et al., Reference Feeney, Finucane, Savva, Cronin, Beatty, Nolan and Kenny2013; Nolan et al., Reference Nolan, Loskutova, Howard, Moran, Mulcahy, Stack and Beatty2014; Renzi et al., Reference Renzi, Dengler, Puente, Miller and Hammond2014; Vishwanathan, Iannaccone, et al., Reference Vishwanathan, Iannaccone, Scott, Kritchevsky, Jennings, Carboni and Johnson2014). Unlike serum levels, one advantage of MPOD is that it represents a measure of L and Z already incorporated into central nervous system tissue and thus may be a better indicator of longer-term dietary intakes.

Although serum levels of L and Z are positively correlated with MPOD (typical r values are around 0.30; e.g., Renzi, Hammond, Dengler, & Roberts, Reference Renzi, Hammond, Dengler and Roberts2012), they represent distinct measures (e.g., Beatty, et al., Reference Beatty, Nolan, Kavanagh and O’Donovan2004; Burke, Curran-Celentano, & Wenzel, Reference Burke, Curran-Celentano and Wenzel2005). For example, one study assessed both serum L and Z and MPOD each month for 24 months and found that MPOD mean and variance were relatively stable, while serum concentrations were more variable; additionally, variations in MPOD and serum concentrations were not linearly related (Nolan et al., Reference Nolan, Stack, Mellerio, Godhinio, O’Donovan, Neelam and Beatty2006). Another study demonstrated that after discontinuing supplementation of L and Z, serum concentrations quickly returned to baseline, whereas changes in MPOD lasted for up to 100 days (Beatty et al., Reference Beatty, Nolan, Kavanagh and O’Donovan2004; Hammond et al., Reference Hammond, Johnson, Russell, Krinsky, Yeum, Edwards and Snodderly1997). These findings are consistent with the interpretation that serum concentrations of L and Z more closely reflect recent or “acute” dietary factors, whereas MPOD, which has a slower biological turnover, reflects more stable L and Z levels acquired over time.

The mechanisms underlying the relation of L and Z to cognitive functioning remain to be fully elucidated. In light of findings suggesting oxidative stress and inflammation play important roles in dementia and cognitive decline more broadly (Engelhart et al., Reference Engelhart, Geerlings, Meijer, Kiliaan, Ruitenberg, van Swieten and Breteler2004; Finkel & Holbrook, Reference Finkel and Holbrook2000; Pappolla et al., Reference Pappolla, Smith, Bryant-Thomas, Bazan, Petanceska, Perry and Refolo2002; Teunissen et al., Reference Teunissen, Van Boxtel, Bosma, Bosmans, Delanghe, De Bruijn and De Vente2003), it is possible that L and Z exert neuroprotective effects via their antioxidant and/or anti-inflammatory properties (Johnson, Reference Johnson2012). More specifically, L and Z quench reactive oxygen molecules to prevent free radical attack (Johnson, Reference Johnson2014) while altering inflammation-related gene expression (Bian et al., Reference Bian, Gao, Zhou, Qin, Taylor, Johnson and Shang2012), pro-inflammatory factor production (Li et al., Reference Li, Fung, Fu, Wong, Chan and Lo2012), and inflammatory cytokine signaling to buffer neural damage (Sasaki et al., Reference Sasaki, Ozawa, Kurihara, Noda, Imamura, Kobayashi and Tsubota2009). Carotenoids may also impact cognition by enhancing interneuronal communication through facilitation of signaling compound exchange at gap junctions (i.e., cell-to-cell channels) and by providing structural support to synaptic membranes (Krinsky, Mayne, & Sies, Reference Krinsky, Mayne and Sies2004; Stahl & Sies, Reference Stahl and Sies2001). Studies using animal models have supported the possibility of such mechanisms, demonstrating that carotenoid administration reduces neurodegeneration, ameliorates oxidative stress and inflammation, and improves cholinergic and mitochondrial dysfunction in brain regions relevant to cognitive aging, such as cerebral cortex and hippocampi (Arnal et al., Reference Arnal, Miranda, Barcia, Bosch-Morell and Romero2010; Binawade & Jagtap, Reference Binawade and Jagtap2013; Kuhad, Sethi, & Chopra, Reference Kuhad, Sethi and Chopra2008; Muriach et al., Reference Muriach, Bosch-Morell, Alexander, Blomhoff, Barcia, Arnal and Miranda2006; Nakashima et al., Reference Nakashima, Ohsawa, Konishi, Hasegawa, Kumamoto, Suzuki and Ohta2009). Importantly, these neuroprotective actions are associated with improvements in cognitive performance on tests of learning and memory (Binawade & Jagtap, Reference Binawade and Jagtap2013; Kuhad et al., Reference Kuhad, Sethi and Chopra2008; Nakashima et al., Reference Nakashima, Ohsawa, Konishi, Hasegawa, Kumamoto, Suzuki and Ohta2009).

The present study aimed to further illuminate mechanisms by which L and Z relate to cognitive functioning in older adults using functional magnetic resonance imaging (fMRI) of verbal memory performance. fMRI has demonstrated sensitivity to changes in neural activation in healthy and pathologically aging older adults on memory tasks as well as to the effects of memory-enhancing interventions, including both drug and antioxidant therapies (e.g., Bookheimer et al., Reference Bookheimer, Renner, Ekstrom, Li, Henning, Brown and Small2013; Dickerson et al., Reference Dickerson, Salat, Bates, Atiya, Killiany, Greve and Sperling2004; Gutchess et al., Reference Gutchess, Welsh, Hedden, Bangert, Minear, Liu and Park2005; Lorenzi et al., Reference Lorenzi, Beltramello, Mercuri, Canu, Zoccatelli, Pizzini and Frisoni2011; Saykin et al., Reference Saykin, Flashman, Frutiger, Johnson, Mamourian, Moritz and Weaver1999). To the authors’ knowledge, this represents the first investigation in which a neuroimaging technique was used to provide an in vivo assessment of the impact of L and Z on brain function.

According to the scaffolding theory of aging and cognition (STAC), cognitive functioning is preserved in the face of age-related neural insult through an ongoing process of reorganization of existing neural connections and recruitment of additional neural circuitry (Park & Reuter-Lorenz, Reference Park and Reuter-Lorenz2009). “Compensatory scaffolding” is considered to be an adaptive, dynamic process that occurs in response to intrinsic (e.g., biological aging) or extrinsic (e.g., task demands) neural challenges to maintain cognitive performance (Park & Reuter-Lorenz, 2009). It is reflected in neuroimaging studies as increased bilateral activation and/or overactivation in certain regions (e.g., prefrontal cortex; e.g., Cabeza et al., Reference Cabeza, Grady, Nyberg, McIntosh, Tulving, Kapur and Craik1997; Cabeza, Anderson, Locantore, & McIntosh, Reference Cabeza, Anderson, Locantore and McIntosh2002; Fera et al., Reference Fera, Weickert, Goldberg, Tessitore, Hariri, Das and Mattay2005; Haung, Polk, Goh, & Park, Reference Huang, Polk, Goh and Park2012). The notion that additional neural activity reflects a compensatory neurocognitive process is supported by reduced hemispheric asymmetry as the complexity of a given task increases (e.g., Banich, Reference Banich1998; Hillary, Genova, Chiaravalloti, Rypma, & DeLuca, Reference Hillary, Genova, Chiaravalloti, Rypma and DeLuca2006), while practice on a given task refines neural networks such that they become less dispersed and more specific (e.g., Petersen, van Mier, Fiez, & Raichle, Reference Petersen, Van Mier, Fiez and Raichle1998). With respect to verbal memory, neuroimaging findings have suggested that age-related cognitive changes, genetic vulnerability to disease, and early stages of neurodegenerative conditions such as dementia are associated with more pronounced and bilateral patterns of brain activity, suggestive of increased neurocognitive effort relative to healthy counterparts (e.g., Bookheimer et al., Reference Bookheimer, Strojwas, Cohen, Saunders, Pericak-Vance, Mazziotta and Small2000; Cabeza et al., Reference Cabeza, Grady, Nyberg, McIntosh, Tulving, Kapur and Craik1997; Dickerson & Sperling, Reference Dickerson and Sperling2008).

In the present study, we evaluated whether L and Z levels are cross-sectionally related to neurobiological efficiency in community-dwelling older adults via promotion of more honed neural networks and reduced need for compensatory scaffolding in response to age-related neural deterioration. MPOD and serum concentrations of L and Z were assessed alongside performance on a verbal memory task in which participants were asked to learn and recall word pairs (Bookheimer et al., Reference Bookheimer, Strojwas, Cohen, Saunders, Pericak-Vance, Mazziotta and Small2000). Lower MPOD and serum L and Z were hypothesized to predict greater compensatory recruitment during memory encoding and retrieval as evidenced by increased neural activity required to meet task demands (i.e., neurobiological inefficiency). For memory encoding, this pattern of activity was anticipated in medial temporal lobe, supramarginal and angular gyri, precuneus, dorsolateral and ventrolateral prefrontal cortex, anterior and posterior cingulate gyrus, Broca’s area, cerebellum, and premotor areas, consistent with regions-of-interest that have demonstrated involvement in verbal memory in other studies (e.g., Binder, Desai, Graves, & Conant, Reference Binder, Desai, Graves and Conant2009; Bookheimer et al., Reference Bookheimer, Strojwas, Cohen, Saunders, Pericak-Vance, Mazziotta and Small2000; Cabeza & Nyberg, Reference Cabeza and Nyberg2000; Clément & Belleville, Reference Clément and Belleville2009).

With the exception of the cerebellum, brain activation was generally expected to be left-lateralized (Binder et al., Reference Binder, Desai, Graves and Conant2009; Cabeza & Nyberg, 2000). A similar frontotemporoparietal network was hypothesized for memory retrieval, although brain activity was expected to show greater tendency for right-lateralization and to evidence greater involvement of anterior prefrontal cortex and medial parieto-occipital areas, including retrosplenial cortex and cuneus (Cabeza & Nyberg 2000). Behaviorally, greater MPOD and serum L and Z were expected to predict enhanced cognitive performance on measures of word recall. Given that serum and retinal concentrations of L and Z and their isomers have been positively related in previous studies, we expected that both measures would follow the same general pattern of negative relation to brain activity and positive relation to behavioral measures of word recall. However, because serum concentrations represent acute L and Z levels and MPOD represents acquired levels, results were not expected to be identical in all hypothesized regions-of-interest.

METHOD

Participants

Data for the present study were derived from a larger intervention study evaluating the relationship between cognition and diet in community-dwelling older adults (65–86 years) recruited from the surrounding area via advertisements, flyers, and electronic media (e.g., listservs). Exclusion criteria included left-handedness, traumatic brain injury, age-related macular degeneration in either eye, gastric conditions with potential to interfere with L/Z absorption (gastric ulcer, gastric band or bypass, Crohn’s disease, ulcerative colitis), corrected visual acuity poorer than 20:40, MRI incompatibility, and/or evidence of dementia or other neurological disorder. Of the participants who were eligible for inclusion and for which neuroimaging, serum, and MPOD data were collected (N=50), 6 were unable to complete the MRI process (e.g., physical discomfort, fatigue, or obvious failure to follow task instructions) and behavioral data from one individual were lost due to technical malfunction, leaving a sample size of 43 for final analyses. Participants were compensated $100 for their time and effort. The study was approved by the University of Georgia Institutional Review Board for safety and ethical treatment of participants, and the tenets of the Declaration of Helsinki were adhered to at all times by all study personnel.

Measures

Wechsler test of adult reading

The Wechsler Test of Adult Reading (WTAR; The Psychological Corporation, 2001) was administered to estimate premorbid intellectual functioning (Wechsler, Reference Wechsler2001). The WTAR provides a Full-Scale Intelligence Quotient (FSIQ) estimate based on an algorithm that incorporates an examinee’s ability to pronounce a list of words as well as demographic (i.e., age, education, race, sex, and geographic region) variables.

Geriatric depression scale

Depressive symptomatology was assessed using the Geriatric Depression Scale (GDS; Yesavage et al., Reference Yesavage, Brink, Rose, Lum, Huang, Adey and Leirer1983). The GDS is a self-report instrument comprised of 30 items of yes/no format and is scored on a 0–30 scale, with higher scores indicating greater levels of depression.

Serum lutein and zeaxanthin

Details of serum analysis can be found elsewhere (Handelman, Shen, & Krinsky, Reference Handelman, Shen and Krinksy1992; Qin et al., Reference Qin, Yeum, Johnson, Krinsky, Russell and Tang2008). Briefly, a total of 7 mL of whole blood was collected via venipuncture by a certified phlebotomist. After collection, samples were immediately placed on ice and centrifuged cold for 15 min. Following centrifugation, serum was collected and aliquoted into 1-mL cryotubes and frozen at −80°C for analysis.

Frozen serum aliquots were thawed to a temperature of 23°C, and precipitated with ethanol. The fat soluble carotenoids were extracted from the aqueous suspension with n-hexane/chloroform. After centrifugation, an aliquot of the organic phase was evaporated to dryness, re-dissolved in mobile phase and prepared for injection using an autoinjection system. L/Z was analyzed using a Hewlett Packard/Agilent Technologies 1100 series high performance liquid chromatography (HPLC) system with a photodiode array detector (Agilent Technologies, Palo Alto, CA). A 5 μm, 200 A° polymeric C30 reverse-phase column (Pronto-SIL, MAC-MOD Analytical Inc., Chadds Ford, PA) was used to separate the analytes.

The HPLC mobile phase solvent A consists of methanol/tert-butyl methyl ether/water (83:15:2, v/v/v, with 1.5% ammonium acetate in the water) and solvent B is methanol/tert-butyl methyl ether/water (8:90:2, v/v/v, with 1% ammonium acetate in the water). The gradient procedure at a flow rate of 1 mL/min begins at 100% Solvent A for 2 min to 70% Solvent A over a 6-min linear gradient and held at 70% A for 3 min, then a 10-min linear gradient to 45% Solvent A and a 2-min hold at 45% Solvent A, then a 10-min linear gradient to 5% Solvent A, a 4-min hold at 5% Solvent A and, finally, a 2-min linear gradient back to 100% Solvent A. The system is held at 100% Solvent A for 10 min for equilibration back to initial conditions (Qin et al., Reference Qin, Yeum, Johnson, Krinsky, Russell and Tang2008).

Serum L and Z were analyzed separately via HPLC. To obtain a combined serum L+Z value, serum L levels (μmol/L) were added to serum Z levels (μmol/L). The combined L+Z value was used in all subsequent analyses. To assess the daily and long-term laboratory performance of the HPLC plasma analytics, dedicated control plasma was used following standardization with SRM 968 c (Standard Reference Materials, National Institute of Standards and Technology, Gaithersburg, MD).

Macular pigment optical density

Macular pigment optical density (MPOD) was evaluated using customized heterochromatic flicker photometry, as described previously (Stringham et al., Reference Stringham, Hammond, Nolan, Wooten, Mammen, Smollon and Snodderly2008). Briefly, a macular densitometer (Macular Metrics; Rehoboth, MA) was used to present participants with a 1° visual stimulus that consisted of two narrow-band LED-based light sources, peaking at 460 nm and 570 nm. The light sources were presented in square-wave, counter-phase orientation to present the appearance of flicker. Before measurement, each participant’s critical flicker fusion frequency was measured using only the mid-wave portion of the stimulus, so that the task could be customized to the individual viewer. Following determination of customized flicker sensitivity, participants were asked to fixate on a black dot displayed at the disk’s core.

The radiance of the lower (i.e., 460 nm) waveband was manipulated relative to the 570 nm component to assess the point at which flickering was no longer perceivable. This sequence was again conducted with a 2° target and fixation point at 7° nasally to allow a reference measurement in the parafovea (where MPOD approaches zero). The two loci (i.e., 30 min, derived from the 1° target, and 7° of retinal eccentricity) were then compared to provide the MPOD measurement at 30 min of retinal eccentricity.

Neuroimaging

fMRI task

Participants completed a block design verbal learning task involving unrelated word pairs (e.g., “UP” and “FOOT”) conceptually based on the Wechsler Memory Scale Verbal Paired Associates (Wechsler, Reference Wechsler2009) and similar to previous fMRI paradigms (e.g., Bookheimer et al., Reference Bookheimer, Strojwas, Cohen, Saunders, Pericak-Vance, Mazziotta and Small2000, Reference Bookheimer, Renner, Ekstrom, Li, Henning, Brown and Small2013; Braskie, Small, & Bookheimer, Reference Braskie, Small and Bookheimer2009). The task was programmed using E-Prime software (version 1.2, Psychology Software Tools, Inc., Pittsburgh, PA) and presented through MRI compatible goggles (Resonance Technology Inc., Northridge, CA). Participants responded using a pair of 2-button Cedrus Lumina LU400 MRI compatible response pads (Cedrus, San Pedro, CA). The task consisted of 10 separate learning blocks, control blocks, retrieval blocks, and fixation blocks, presented sequentially in the aforementioned order (i.e., learning, control, retrieval, fixation) for every participant (see Figure 1).

Fig. 1 Verbal Learning Task. The above figure provides a visual schematic of the progression of the verbal learning task. The four blocks (i.e., learning, control, retrieval, and fixation) were presented a total of 10 times, resulting in a total acquisition time of 12 min, 24 s. Five different words pairs were presented in each learning block and 5 sets of XXXXX – YYYYY pairings were presented in each control block. During each retrieval block, participants were asked to recall the second word for five different word pairs.

In the learning blocks, the first word of each pair was presented alone on the left side of the screen (1 s) followed by presentation of the second word on the right side of the screen, such that both words were viewable simultaneously (2 s). There were a total of 10 word pairs, 5 of which were presented in each encoding block. Participants were instructed to respond with their right index finger whenever the second word in the pair appeared, to help verify attention during learning. During the retrieval portion of the task, participants were presented with the first word in each pair (3 s) and asked to mentally recall (to avoid head motion) the second word, consistent with procedures used in similar fMRI-adapted verbal learning paradigms (e.g., Bookheimer et al., Reference Bookheimer, Strojwas, Cohen, Saunders, Pericak-Vance, Mazziotta and Small2000, Reference Bookheimer, Renner, Ekstrom, Li, Henning, Brown and Small2013). Participants were instructed to respond with their right index finger if they remembered the second word or to respond with their left index finger if they did not (maximum score: 50).

Learning and retrieval blocks were interspersed with a control task analogous to the learning block except that Xs (i.e., “XXXXX”) and Ys (i.e., “YYYYY”) were presented instead of word pairs. Participants responded with their right index finger whenever the Ys appeared on the screen. Fixation blocks consisted of a crosshair presented for 6 s. Immediately following the scan, participants were asked to engage in free recall (maximum score: 10) followed by cued recall (maximum score: 10) of the “second word” in each pair to help verify task engagement within the scanner.

MRI acquisition

A General Electric (GE; Waukesha, WI) 3 Tesla Signa HDx MRI system was used to acquire all scans. Structural scans were collected using a high-resolution three-dimensional T1-weighted fast spoiled gradient recall echo sequence [repetition time (TR)=7.5 ms; echo time (TE)=<5 ms; field of view (FOV)=256×256 mm matrix; flip angle=20°; slice thickness=1 mm; 154 axial slices; voxel size=0.94×0.94×1 mm] with a total acquisition time of 6 min, 20 s. This protocol covered the top of the head to the brainstem and collected 176 images.

Functional scans were aligned to the anterior commissure-posterior commissure line and collected axially using a T2*-weighted single shot echo planar imaging (EPI) sequence (TR =1500 ms; TE=25 ms; 90° RF pulse; acquisition matrix =64×64; FOV =220×220 mm; in-plane resolution, 220×64 mm; slice thickness =4 mm; 30 interleaved axial slices; voxel size =3.43×3.43×4 mm) with an acquisition time of 12 min, 24 s. The EPI sequence covered the cortical surface and a portion of the cerebellum, and consisted of 290 volumes. A pair of magnitude and phase images was acquired, lasting 1 min, 40 s each, for fieldmap-based unwarping (TR =700 ms; TE =5.0/7.2 ms; FOV =220×220 mm matrix; flip angle =30°; slice thickness =2 mm; 60 interleaved slices; voxel size =1.72×1.72×2 mm).

Data analysis

Statistical Parametric Mapping (SPM12, Wellcome Department of Cognitive Neurology, London, UK) was used to process and analyze the data. Data were first converted from GE DICOM to NIFTI format with the dcm2nii conversion tool (Rorden, Reference Rorden2007). Preprocessing of functional data included slice time correction to adjust for the non-sequential, interleaved acquisition and realignment of functional images to the first image of the functional scan to correct for head movement. Fieldmaps were created to realign and unwarp images to account for phase and magnitude variations during the scan. Anatomical scans were co-registered to the first image of the functional scan followed by registration of anatomical and functional images to the Montreal Neurological Institute (MNI) template. The anatomical image was segmented to differentiate brain tissue (i.e., white matter and gray matter), cerebrospinal fluid, bone, non-brain soft tissue, and air. Deformation fields were created and applied to functional images to allow spatial normalization to MNI space. Finally, images were smoothed using a 6.75-mm FWHM Gaussian filter.

Following pre-processing, activation maps of encoding minus control task and retrieval minus control task were created using the General Linear Model (SPM12b). All trials were included in analyses, regardless of occasional failure to respond or self-perceived recall success. A statistical threshold of p<.05, family-wise-error (FWE) corrected, and a minimum of eight contiguous voxels were selected given optimal balance between Type I and Type II error rates (Lazar, Reference Lazar2008). Regression-based analyses were conducted to determine the relation of L and Z levels to voxel activity within hypothesized regions-of-interest during memory encoding and recall.

The relation of L and Z levels to behavioral measures of recall was also evaluated using regression analyses. More specifically, the number of self-reported successful retrievals across the entire task and on the final 10 retrieval trials only (the assumed point of maximal learning), as well as the number of verified cued successful retrievals measured immediately post-scan, were considered as dependent variables in three separate regressions.

Procedure

Following recruitment and screening for exclusion criteria (described above), data were collected across three testing sessions. During the first session, written informed consent was obtained and MPOD was measured. Participants completed the GDS and WTAR in the second session, as well as a handful of other measures that were part of the larger intervention study and not a focus of the present analyses. The third session was conducted at the University of Georgia Bio-Imaging Research Center, which houses the MRI scanner. Before being placed in the MRI environment, participants practiced an abbreviated version of the verbal learning task on a desktop computer to ensure understanding of task directions and provide the opportunity to ask questions. The MRI protocol included structural imaging first, followed by collection of phase and magnitude images, and finally acquisition of functional data during the verbal learning task. Participants were debriefed and thanked at the end of the testing session.

RESULTS

Sample Characteristics and Verbal Learning Behavioral Responses

Serum L+Z levels, MPOD, and demographic information including age, years of formal education, gender and racial composition, and estimated intellectual functioning are presented in Table 1. It is notable that the sample was entirely Caucasian and tended to be well educated.

Table 1 Descriptive statistics (N=43)

Note. o.d. represents the log ratio of transmitted light passing through the macula.

GDS=Geriatric Depression Scale; FSIQ=Full-Scale Intelligence Quotient from the Wechsler Test of Adult Reading; MPOD=macular pigment optical density; o.d.=optical density.

a Data only available for 42 participants.

Table 1 also provides descriptive statistics related to behavioral performance on the verbal learning task. While in the scanner, participants, on average, self-reported recall of the second word in the pair on 37 of the 50 total recall trials (74%). The group average self-reported (within scanner) recall during the last two recall blocks only (the assumed point of maximal learning) was 9 of the 10 total word pairs (90%). As expected, self-reported recall within the scanner significantly correlated with actual cued recall immediately following the scan (r=0.45; p=.002), differing from each other by less than two words, on average (mean difference=1.67; SD=2.00, 3 participants with discrepancy>4 words). The observed correlation provides evidence that participants were engaged in the task and actively attempting to learn and recall word pairs within the scanner. In addition, discrepancy scores between within-scanner recall and actual post-scan recall were unrelated to MPOD (p=.593) or serum L+Z (p=.073).

Age and education were considered as potential covariates in analyses but given nonsignificant zero-order bivariate correlations to MPOD (r=.17; p=.279, and r=.10; p=.521, respectively), serum L+Z (r=−.02; p=.926, and r=.07; p=.681, respectively), and behavioral measures of verbal learning, they were not included in the regression models.

Whole-Brain Analyses

Using a FWE corrected p<.05 and minimum of eight contiguous voxels, the encoding minus control contrast revealed widespread activation in regions commonly associated with verbal learning task performance, including left inferior frontal regions (Broca’s area), middle frontal gyri, hippocampus, precentral gyrus, and occipital lobe (see Figure 2). The recall minus control contrast similarly revealed diffuse activation in several regions including paracingulate gyri, insular cortex, middle frontal gyrus, and occipital lobe (see Figure 3).

Fig. 2 Panel (a) depicts whole-brain analyses of the encoding minus control contrast (independent of lutein and zeaxanthin levels) superimposed on a single-subject anatomical template in MNI space provided by MRIcron (http://www.mricro.com/mricron/install.html). To conserve space, only six slices were selected for visualization based on largest extent activation and thus not all voxel activity is represented. Panel (b) displays brain activation significantly related to lutein and zeaxanthin concentrations during encoding. Areas in green represent increased activation associated with lower MPOD levels, while areas in red represent increased activation associated with lower serum lutein and zeaxanthin. Only six slices were selected based on largest extent activation to showcase the relation of lutein and zeaxanthin to brain activity and thus not every significant cluster is displayed.

Fig. 3 Panel (a) depicts whole-brain analyses of the recall minus control contrast (independent of lutein and zeaxanthin levels) superimposed on a single-subject anatomical template in MNI space provided by MRIcron (http://www.mricro.com/mricron/install.html). To conserve space, only six slices were selected for visualization based on largest extent activation and thus not all significant voxel activity is represented. Panel (b) displays brain activation significantly related to lutein and zeaxanthin concentrations during retrieval. Areas in green represent increased activation associated with lower MPOD levels, while areas in red represent increased activation associated with lower serum lutein and zeaxanthin. Only six slices were selected based on largest extent activation to showcase the relation of lutein and zeaxanthin to brain activity and thus not every significant cluster is displayed.

Lutein and Zeaxanthin Levels and fMRI Performance

Behavioral

Serum L+Z and MPOD were unrelated to overt within-scanner behavioral performance on the verbal learning task. More specifically, MPOD was not a significant predictor of the number of self-reported successful retrievals across the entire paradigm (r=−.001; p=.993) nor across the last 10 trials only (i.e., the final block; r=.103; p=.511). Similarly, serum L+Z concentrations were not significantly related to word retrieval across the entire paradigm (r=.236; p=.127) nor on the final block (r=.275; p=.074). MPOD and serum L+Z levels also displayed nonsignificant relations to actual cued recall post-scan (r=.137; p=.380, and r=−.084; p=.591, respectively).

Functional imaging

Following the encoding minus control contrast (p<.05, FWE, minimal voxel cluster=8), regression-based analyses of blood-oxygen-level-dependent BOLD) signal demonstrated that lower MPOD levels were associated with significantly greater brain activity (i.e., neural inefficiency) in several regions relevant to verbal learning including left insular cortex, right middle temporal gyrus, left supramarginal gyrus, and left cerebellum (p<.01; see Table 2 and Figure 2). With respect to the recall minus control contrast (p<.05; FWE, minimal voxel cluster=8), lower MPOD was associated with increased activation in left inferior frontal gyrus, left insular cortex, left planum polare, right middle frontal gyrus, left cerebellum, and left and right occipital pole (p<.01; see Table 3 and Figure 3). As indicated in Tables 2 and 3, effect sizes for MPOD during encoding and retrieval ranged from r=.36 to r=.46.

Table 2 Relationship of lutein and zeaxanthin to brain activation during encoding (N=43)

Note. The above table includes brain activity that was significantly and negatively associated with lutein and zeaxanthin levels during encoding of word pairs.MPOD=macular pigment optical density. x, y, and z coordinates are in MNI space (mm). L=left and R=right.*=cluster overlap with preceding row.

Table 3 Relationship of lutein and zeaxanthin to brain activation during recall (N=43)

Note. The above table includes brain activity that was significantly and negatively associated with lutein and zeaxanthin levels during retrieval of word pairs. x, y, and z coordinates are in MNI space (mm).

MPOD=macular pigment optical density. L=left and R=right.

L+Z concentrations in serum similarly demonstrated a negative relationship with BOLD signal in several brain regions during encoding including left parietal operculum, occipital cortex bilaterally (superior division), left postcentral gyrus, and left precentral gyrus (p<.01; see Table 2 and Figure 2). During recall, less L+Z in serum was associated with increased activation in left central opercular cortex, left superior parietal lobule, and left lateral occipital cortex (p<.01; see Table 3 and Figure 3). As represented in Tables 2 and 3, effect sizes for L+Z in serum during encoding and retrieval ranged from r=.37 to r=.49.

DISCUSSION

L and Z are two carotenoids previously shown to accumulate in human brain tissue, improve cognitive functioning, and reduce risk of age-related degenerative diseases (e.g., Akbaraly et al., Reference Akbaraly, Faure, Gourlet, Favier and Berr2007; Johnson, Reference Johnson2014; Johnson et al., Reference Johnson, Vishwanathan, Johnson, Hausman, Davey, Scott and Poon2013; Nolan et al., Reference Nolan, Loskutova, Howard, Moran, Mulcahy, Stack and Beatty2014; Rinaldi et al., Reference Rinaldi, Polidori, Metastasio, Mariani, Mattioli, Cherubini and Mecocci2003; Vishwanathan, Iannaccone, et al., Reference Vishwanathan, Iannaccone, Scott, Kritchevsky, Jennings, Carboni and Johnson2014). To date, no studies have investigated the neural mechanisms underlying these relationships. This study sought to determine whether L+ Z are related to neural efficiency during a verbal learning and memory task.

Initial whole brain analyses revealed diffuse activation in regions commonly associated with verbal learning and retrieval, replicating previous findings (e.g., Bookheimer et al., Reference Bookheimer, Strojwas, Cohen, Saunders, Pericak-Vance, Mazziotta and Small2000; Cabeza et al., Reference Cabeza, Grady, Nyberg, McIntosh, Tulving, Kapur and Craik1997; Dickerson & Sperling, Reference Dickerson and Sperling2008). As expected, lower levels of both MPOD and serum L+Z concentrations were associated with increased activation (i.e., neural inefficiency) in several of these regions, though results were not identical for the two measures. Overall, serum concentrations predicted activity in regions commonly involved in somatosensory functions (e.g., postcentral gyrus, parietal and central operculum, superior parietal lobule; Eickhoff et al., Reference Eickhoff, Jbabdi, Caspers, Laird, Fox, Zilles and Behrens2010; Molholm et al., Reference Molholm, Sehatpour, Mehta, Shpaner, Gomez-Ramirez, Ortigue and Foxe2006), whereas MPOD was associated with activity in regions more involved in language processing (e.g., inferior frontal gyrus, middle temporal gyrus, supramarginal gyrus, planum polare; Cabeza & Nyberg, Reference Cabeza and Nyberg2000; Costafreda et al., Reference Costafreda, Fu, Lee, Everitt, Brammer and David2006; Friederici, Meyer, & von Cramon, Reference Friederici, Meyer and von Cramon2000). This pattern suggests that acute intake of L+Z, as represented by serum concentrations, may boost performance by aiding in somatosensory processing. Carotenoid consumption over longer periods of time, as represented by MPOD, may increase performance via more efficient higher-order language skills.

Regardless of the specific cognitive functions implicated, pathological aging and cognitive decline in late life have been associated with dysfunction in many of the brain regions that demonstrated a functional relationship to L+Z levels, including left inferior frontal gyrus (Bookheimer et al., Reference Bookheimer, Strojwas, Cohen, Saunders, Pericak-Vance, Mazziotta and Small2000; Clément & Bellville, Reference Clément and Belleville2009), insula (Xie et al., Reference Xie, Bai, Yu, Shi, Yuan, Chen and Li2012), middle temporal gyrus (Convit et al., Reference Convit, de Asis, de Leon, Tarshish, De Santi and Rusinek2000), middle frontal gyrus (Rajah, Languay, & Grady, Reference Rajah, Languay and Grady2011), and central and parietal operculum (Trachtenberg et al., Reference Trachtenberg, Filippini, Ebmeier, Smith, Karpe and Mackay2012). The present results are, therefore, consistent with past studies concluding that a diet rich in L+Z may buffer pathobiological processes in old age by enhancing neural efficiency in structures at risk for deterioration.

Both MPOD and serum L+Z levels was associated with neural efficiency in primary visual areas, suggesting that these carotenoids more generally improve visual processing (as shown behaviorally; Renzi & Hammond, Reference Renzi and Hammond2010) beyond the level of the retina. This finding holds particular relevance among older adults, who exhibit a high prevalence of visual difficulties due to conditions such as macular degeneration, which in turn have been shown to impact functional properties at a neural level (e.g., Baker, Peli, Knouf, & Kanwisher, Reference Baker, Peli, Knouf and Kanwisher2005).

Contrary to expectation, (serum or MP) L and Z did not predict behavioral performance on the verbal memory task. In many respects, however, this observation is consistent with the STAC in the sense that individuals with lower L and Z levels were required to recruit additional neural resources to maintain a similar level of cognitive performance as peers with higher L and Z levels (Park & Reuter-Lorenz, Reference Park and Reuter-Lorenz2009). It is also possible that there was a ceiling effect given the generally high level of cognitive functioning apparent within the present sample and that a more sensitive cognitive measure with greater variability in scores would reveal a relationship. Despite significant correlations with actual cued recall post-scan, the reliance on self-reported cognitive performance within the scanner limited conclusions regarding task accuracy and may have influenced the observed results.

Another important limitation of the present study is its cross-sectional design, which prevents conclusions regarding the directionality of the observed relationship between L+Z and neural efficiency. Although longitudinal studies have indicated that carotenoid consumption preserves neurocognitive health (Min & Min, Reference Min and Min2014), other dietary factors (e.g., antioxidant-rich fruits) left uncontrolled in the present analyses have been shown to impact brain function as measured with fMRI (Bookheimer et al., Reference Bookheimer, Renner, Ekstrom, Li, Henning, Brown and Small2013) and the results should be interpreted with this in mind. For example, it is possible that L and Z levels serve as proxies for other features of a healthful diet that relate to brain health, such as omega-3 fatty acid intake (Witte et al., Reference Witte, Kerti, Hermannstädter, Fiebach, Schreiber, Schuchardt and Flöel2014), and randomized controlled trials will be required to better address issues of causality while isolating the effects of the xanthophylls on neural activity.

Additionally, our sample was entirely Caucasian, highly educated, and, generally, very cognitively healthy. Thus, the generalizability of our findings to individuals characterized by greater diversity in socioeconomic status, racial background, and cognitive function may be limited and represents a critical avenue for future research. Finally, despite the strong chemical and structural similarities between L and Z, future neuroimaging studies may benefit from considering their unique effects in analyses rather than combining them as we have in the present investigation.

To our knowledge, this is the first study to investigate the association of L and Z to cognition using fMRI. Results indicate that L and Z concentrations, measured both acutely (serum) and acquired (retinal), enhance neural efficiency during verbal learning and memory in older adults. Our findings also offer a possible neural mechanism underlying previous findings showing a positive relation between these carotenoids and performance on cognitive tasks (e.g., Feeney et al., Reference Feeney, Finucane, Savva, Cronin, Beatty, Nolan and Kenny2013; Johnson, Reference Johnson2014; Renzi et al., Reference Renzi, Dengler, Puente, Miller and Hammond2014; Vishwanathan, Iannaccone, et al., Reference Vishwanathan, Iannaccone, Scott, Kritchevsky, Jennings, Carboni and Johnson2014). More broadly, the present study adds to the paucity of research investigating the critical relationship between diet and brain health, while identifying a modifiable lifestyle factor that may serve to promote neurocognitive functioning in the rapidly expanding older adult population.

ACKNOWLEDGMENTS

This research project was funded in part by Abbott Nutritional Products (Columbus, OH; research grant to B.R.H., L.M.R., L.S.M.) and the University of Georgia’s Bio-Imaging Research Center (administrative support, L.S.M.). DSM Nutritional Products (Switzerland) provided the supplements and placebos for the larger intervention study from which the data for the present study were derived. Additionally, L.M.R. was an employee of Abbott Nutrition during a portion of the grant period while holding a joint appointment at the University of Georgia. B.R.H. has consulted for Abbott Nutrition. No other potential conflicts of interest exist for any of the study authors, including C.A.L., C.M.M., and J.M.C. All statistical analyses were completed independently of supporting agencies.

References

REFERENCES

Akbaraly, N., Faure, H., Gourlet, V., Favier, A., & Berr, C. (2007). Plasma carotenoid levels and cognitive performance in an elderly population: Results of the EVA study. Journals of Gerontology, Series A, Biological Sciences and Medical Sciences, 62(3), 308316.Google Scholar
Arnal, E., Miranda, M., Barcia, J., Bosch-Morell, F., & Romero, F. (2010). Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex. Journal of Neuroscience, 166(1), 271278.Google Scholar
Baker, C., Peli, E., Knouf, N., & Kanwisher, N. (2005). Reorganization of visual processing in macular degeneration. Journal of Neuroscience, 25(3), 614618.CrossRefGoogle ScholarPubMed
Banich, M. (1998). The missing link: The role of interhemispheric interaction in attentional processing. Brain and Cognition, 36(2), 128157.Google Scholar
Beatty, S., Nolan, J., Kavanagh, H., & O’Donovan, O. (2004). Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Archives of Biochemistry and Biophysics, 430, 7076.CrossRefGoogle ScholarPubMed
Bian, Q., Gao, S., Zhou, J., Qin, J., Taylor, A., Johnson, E., & Shang, F. (2012). Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells. Free Radical Biology and Medicine, 53(6), 12981307.Google Scholar
Binawade, Y., & Jagtap, A. (2013). Neuroprotective effect of lutein against 3-nitropropionic acid–induced Huntington’s disease–like symptoms: Possible behavioral, biochemical, and cellular alterations. Journal of Medicinal Food, 16(10), 934943.Google Scholar
Binder, J.R., Desai, R.H., Graves, W.W., & Conant, L.L. (2009). Where is the semantic system? A critical review and meta-analysis of 120 functional neuroimaging studies. Cerebral Cortex, 19(12), 27672796.CrossRefGoogle ScholarPubMed
Bookheimer, S., Renner, B., Ekstrom, A., Li, Z., Henning, S., Brown, J., & Small, G. (2013). Pomegranate juice augments memory and fMRI activity in middle-aged and older adults with mild memory complaints. Evidence-Based Complementary and Alternative Medicine, 2013, 946298.Google Scholar
Bookheimer, S., Strojwas, M., Cohen, M., Saunders, A., Pericak-Vance, M., Mazziotta, J., & & Small, G. (2000). Patterns of brain activation in people at risk for Alzheimer’s disease. New England Journal of Medicine, 343(7), 450456.Google Scholar
Bone, R.A., Landrum, J.T., Dixon, Z., Chen, Y., & Llerena, C.M. (2000). Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Experimental Eye Research, 71(3), 239245.Google Scholar
Bone, R., Landrum, J., & Tarsis, S. (1985). Preliminary identification of the human macular pigment. Vision Research, 25(11), 15311535.Google Scholar
Braskie, M., Small, G., & Bookheimer, S. (2009). Entorhinal cortex structure and functional MRI response during an associative verbal memory task. Human Brain Mapping, 30(12), 39813992.Google Scholar
Burke, J., Curran-Celentano, J., & Wenzel, A. (2005). Diet and serum carotenoid concentrations affect macular pigment optical density in adults 45 years and older. Journal of Nutrition, 135(5), 12081214.CrossRefGoogle ScholarPubMed
Cabeza, R., Anderson, N., Locantore, J., & McIntosh, A. (2002). Aging gracefully: Compensatory brain activity in high-performing older adults. Neuroimage, 17(3), 13941402.Google Scholar
Cabeza, R., Grady, C., Nyberg, L., McIntosh, A., Tulving, E., Kapur, S., & Craik, F. (1997). Age-related differences in neural activity during memory encoding and retrieval: A positron emission tomography study. Journal of Neuroscience, 17(1), 391400.Google Scholar
Cabeza, R., & Nyberg, L. (2000). Imaging Cognition II: An empirical review of 275 PET and fMRI studies. Journal of Cognitive Neuroscience, 12(1), 147.CrossRefGoogle Scholar
Cardinault, N., Gorrand, J., Tyssandier, V., Grolier, P., Rock, E., & Borel, P. (2003). Short-term supplementation with lutein affects biomarkers of lutein status similarly in young and elderly subjects. Experimental Gerontology, 38, 573582.CrossRefGoogle Scholar
Clément, F., & Belleville, S. (2009). Test–retest reliability of fMRI verbal episodic memory paradigms in healthy older adults and in persons with mild cognitive impairment. Human Brain Mapping, 30(12), 40334047.CrossRefGoogle ScholarPubMed
Chew, E., Clemons, T., SanGiovanni, J., Danis, R., Ferris, F., Elman, M., & Fish, G. (2014). Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 Report No. 3. Journal of the American Medical Association Ophthalmology, 132(2), 142149.Google Scholar
Chew, E., Clemons, T., Agrón, E., Launer, L., Grodstein, F., & Bernstein, P. (2015). Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function: The AREDS2 randomized clinical trial. Journal of the American Medical Association, 314(8), 791801.Google Scholar
Convit, A., de Asis, J., de Leon, M., Tarshish, C., De Santi, S., & Rusinek, H. (2000). Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease. Neurobiology of Aging, 21(1), 1926.Google Scholar
Costafreda, S., Fu, C., Lee, L., Everitt, B., Brammer, M., & David, A. (2006). A systematic review and quantitative appraisal of fMRI studies of verbal fluency: Role of the left inferior frontal gyrus. Human Brain Mapping, 27(10), 799810.Google Scholar
Craft, N., Haitema, T., Garnett, K., Fitch, K., & Dorey, C. (2004). Carotenoid, tocopherol, and retinol concentrations in elderly human brain. Journal of Nutrition Health and Aging, 8(3), 156162.Google Scholar
Dickerson, B., Salat, D., Bates, J., Atiya, M., Killiany, R., Greve, D., & Sperling, R.A. (2004). Medial temporal lobe function and structure in mild cognitive impairment. Annals of Neurology, 56(1), 2735.CrossRefGoogle ScholarPubMed
Dickerson, B., & Sperling, R. (2008). Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer’s disease: Insights from functional MRI studies. Neuropsychologia, 46(6), 16241635.Google Scholar
Eickhoff, S., Jbabdi, S., Caspers, S., Laird, A., Fox, P., Zilles, K., && Behrens, T. (2010). Anatomical and functional connectivity of cytoarchitectonic areas within the human parietal operculum. Journal of Neuroscience, 30(18), 64096421.CrossRefGoogle ScholarPubMed
Engelhart, M.J., Geerlings, M.I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J.C., & Breteler, M.M. (2004). Inflammatory proteins in plasma and the risk of dementia: The Rotterdam Study. Archives of Neurology, 61(5), 668672.Google Scholar
Feart, C., Letenneur, L., Helmer, C., Samieri, C., Schalch, W., Etheve, S., & Barberger-Gateau, P. (2016). Plasma carotenoids are inversely associated with dementia risk in an elderly French cohort. Journals of Gerontology, Series A, Biological Sciences and Medical Sciences, 71(5), 683688.Google Scholar
Feeney, J., Finucane, C., Savva, G.M., Cronin, H., Beatty, S., Nolan, J.M., && Kenny, R.A. (2013). Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. Neurobiology of Aging, 34(11), 24492456.Google Scholar
Fera, F., Weickert, T.W., Goldberg, T.E., Tessitore, A., Hariri, A., Das, S., & Mattay, V. (2005). Neural mechanisms underlying probabilistic category learning in normal aging. Journal of Neuroscience, 25(49), 1134011348.Google Scholar
Finkel, T., & Holbrook, N. (2000). Oxidants, oxidative stress and the biology of ageing. Nature, 408(6809), 239247.Google Scholar
Friederici, A., Meyer, M., & von Cramon, D. (2000). Auditory language comprehension: An event-related fMRI study on the processing of syntactic and lexical information. Brain and Language, 74(2), 289300.CrossRefGoogle Scholar
Gutchess, A., Welsh, R., Hedden, T., Bangert, A., Minear, M., Liu, L., && Park, D. (2005). Aging and the neural correlates of successful picture encoding: Frontal activations compensate for decreased medial-temporal activity. Journal of Cognitive Neuroscience, 17(1), 8496.Google Scholar
Hammond, B.R., Johnson, E.J., Russell, R.M., Krinsky, N., Yeum, K., Edwards, R., & & Snodderly, D. (1997). Dietary modification of human macular pigment density. Investigative Opthalmology & Visual Science, 38(9), 17951801.Google Scholar
Hammond, B., Wooten, B., & Smollon, B. (2005). Assessment of the validity of in vivo methods of measuring human macular pigment optical density. Optometry & Vision Science, 82(5), 387404.Google Scholar
Handelman, G.J., Shen, B., & Krinksy, N.I. (1992). High resolution analysis of carotenoids in human plasma by high-performance liquid chromatography. Methods in Enzymology, 213, 336346.Google Scholar
Hillary, F.G., Genova, H.M., Chiaravalloti, N.D., Rypma, B., & DeLuca, J. (2006). Prefrontal modulation of working memory performance in brain injury and disease. Human Brain Mapping, 27(11), 837847.Google Scholar
Huang, C.-M., Polk, T., Goh, J., & Park, D. (2012). Both left and right posterior parietal activations contribute to compensatory processes in normal aging. Neuropsychologia, 50(1), 5566.Google Scholar
Johnson, E.J. (2012). A possible role for lutein and zeaxanthin in cognitive function in the elderly. American Journal of Clinical Nutrition, 96(5), 11611165.CrossRefGoogle ScholarPubMed
Johnson, E. (2014). Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutrition Reviews, 72(9), 605612.Google Scholar
Johnson, E., Maras, J.E., Rasmussen, H.M., & Tucker, K.L. (2010). Intake of lutein and zeaxanthin differ with age, sex, and ethnicity. Journal of the American Dietetic Association, 110(9), 13571362.Google Scholar
Johnson, E., McDonald, K., Caldarella, S., Chung, H., Troen, A., & Snodderly, D. (2008). Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutritional Neuroscience, 11(2), 7583.Google Scholar
Johnson, E.J., Vishwanathan, R., Johnson, M.A., Hausman, D.B., Davey, A., Scott, T.M., & Poon, L.W. (2013). Relationship between serum and brain carotenoids, α-tocopherol, and retinol concentrations and cognitive performance in the oldest old from the Georgia Centenarian Study. Journal of Aging Research, 2013, 951786.Google Scholar
Kang, J., Ascherio, A., & Grodstein, F. (2005). Fruit and vegetable consumption and cognitive decline in aging women. Annals of Neurology, 57(5), 713720.Google Scholar
Krinsky, N. (2002). Possible biologic mechanisms for a protective role of xanthophylls. The Journal of Nutrition, 132(3), 540542.Google Scholar
Krinsky, N., Mayne, S., & Sies, H. (2004). Carotenoids in health and disease. Florida: CRC Press.Google Scholar
Kuhad, A., Sethi, R., & Chopra, K. (2008). Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sciences, 83(3-4), 128134.Google Scholar
Lazar, N. (2008). The statistical analysis of functional MRI data. New York: Springer.Google Scholar
Li, S., Fung, F., Fu, Z., Wong, D., Chan, H., & Lo, A. (2012). Anti-inflammatory effects of lutein in retinal ischemic/hypoxic injury: In vivo and in vitro studies. Investigative Ophthalmology and Visual Science, 53(10), 59765984.Google Scholar
Lorenzi, M.M., Beltramello, A., Mercuri, N.B., Canu, E., Zoccatelli, G., Pizzini, F.B., & Frisoni, G.B. (2011). Effect of memantine on resting state default mode network activity in Alzheimer’s disease. Drugs and Aging, 28(3), 205217.Google Scholar
Min, J., & Min, K. (2014). Serum lycopene, lutein and zeaxanthin, and the risk of Alzheimer’s disease mortality in older adults. Dementia and Geriatric Cognitive Disorders, 37(3-4), 246256.Google Scholar
Molholm, S., Sehatpour, P., Mehta, A.D., Shpaner, M., Gomez-Ramirez, M., Ortigue, S., & Foxe, J.J. (2006). Audio-visual multisensory integration in superior parietal lobule revealed by human intracranial recordings. Journal of Neurophysiology, 96(2), 721729.Google Scholar
Morris, M.C., Evans, D., Tangney, C., Bienias, J., & Wilson, R.S. (2006). Associations of vegetable and fruit consumption with age-related cognitive change. Neurology, 67(8), 13701376.Google Scholar
Muriach, M., Bosch-Morell, F., Alexander, G., Blomhoff, R., Barcia, J., Arnal, E., & Miranda, M. (2006). Lutein effect on retina and hippocampus of diabetic mice. Free Radical Biology and Medicine, 41(6), 979984.Google Scholar
Nakashima, Y., Ohsawa, I., Konishi, F., Hasegawa, T., Kumamoto, S., Suzuki, Y., & & Ohta, S. (2009). Preventive effects of Chlorella on cognitive decline in age-dependent dementia model mice. Neuroscience Letters, 464(3), 193198.CrossRefGoogle ScholarPubMed
Nolan, J.M., Loskutova, E., Howard, A.N., Moran, R., Mulcahy, R., Stack, J., & Beatty, S. (2014). Macular pigment, visual function, and macular disease among subjects with Alzheimer’s disease: An exploratory study. Journal of Alzheimer’s Disease, 42(4), 11911202.Google Scholar
Nolan, J.M., Stack, J., Mellerio, J., Godhinio, M., O’Donovan, O., Neelam, K., && Beatty, S. (2006). Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Current Eye Research, 31(2), 199213.Google Scholar
Olmedilla-Alonso, B., Beltrán-de-Miguel, B., Estévez-Santiago, R., & Cuadrado-Vives, C. (2014). Markers of lutein and zeaxanthin status in two age groups of men and women: Dietary intake, serum concentrations, lipid profile and macular pigment optical density. Nutrition Journal, 13(1), 142160.Google Scholar
Pappolla, M.A., Smith, M.A., Bryant-Thomas, T., Bazan, N., Petanceska, S., Perry, G., & Refolo, L.M. (2002). Cholesterol, oxidative stress, and Alzheimer’s disease: Expanding the horizons of pathogenesis. Free Radical Biology and Medicine, 33(2), 173181.CrossRefGoogle ScholarPubMed
Park, D.C., & Reuter-Lorenz, P. (2009). The adaptive brain: Aging and neurocognitive scaffolding. Annual Review of Psychology, 60, 173196.Google Scholar
Petersen, S.E., Van Mier, H., Fiez, J.A., & Raichle, M.E. (1998). The effects of practice on the functional anatomy of task performance. Proceedings of the National Academy of Sciences of the United States of America, 95(3), 853860.Google Scholar
Qin, J.Y., Yeum, K.J., Johnson, E.J., Krinsky, N.I., Russell, R.M., & Tang, G. (2008). Determination of 9-cis β-carotene and ζ-carotene in biological samples. Journal of Nutritional Biochemistry, 19(9), 612618.CrossRefGoogle ScholarPubMed
Rajah, M.N., Languay, R., & Grady, C.L. (2011). Age-related changes in right middle frontal gyrus volume correlate with altered episodic retrieval activity. Journal of Neuroscience, 31(49), 1794117954.CrossRefGoogle ScholarPubMed
Renzi, L., & Hammond, B.R. (2010). The relation between the macular carotenoids, lutein and zeaxanthin, and temporal vision. Ophthalmic and Physiological Optics, 30(4), 351357.Google Scholar
Renzi, L.M., Hammond, B.R., Dengler, M., & Roberts, R. (2012). The relation between serum lipids and lutein and zeaxanthin in the serum and retina: Results from cross-sectional, case-control and case study designs. Lipids in Health and Disease, 11(1), 110.CrossRefGoogle ScholarPubMed
Renzi, L.M., Dengler, M.J., Puente, A., Miller, L.S., & Hammond, B.R. Jr. (2014). Relationships between macular pigment optical density and cognitive function in unimpaired and mildly cognitively impaired older adults. Neurobiology of Aging, 35(7), 16951699.Google Scholar
Rinaldi, P., Polidori, M., Metastasio, A., Mariani, E., Mattioli, P., Cherubini, A., & Mecocci, P. (2003). Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiology of Aging, 24(7), 915919.Google Scholar
Rorden, C. (2007). DCM2NII (Computer software). Retrieved from https://www.nitrc.org/projects/dcm2nii/ Google Scholar
Sasaki, M., Ozawa, Y., Kurihara, T., Noda, K., Imamura, Y., Kobayashi, S., & Tsubota, K. (2009). Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Investigative Opthalmology and Visual Science, 50(3), 1433.Google Scholar
Saykin, A.J., Flashman, L.A., Frutiger, S.A., Johnson, S.C., Mamourian, A.C., Moritz, C.H., & Weaver, J.B. (1999). Neuroanatomic substrates of semantic memory impairment in Alzheimer’s disease: Patterns of functional MRI activation. Journal of the International Neuropsychological Society, 5(5), 377392.Google Scholar
Scanlon, G., Connell, P., Ratzlaff, M., Foerg, B., McCartney, D., Murphy, A., & Loughman, J. (2015). Macular pigment optical density is lower in type 2 diabetes, compared with type 1 diabetes and normal controls. Retina, 35(9), 18081816.Google Scholar
Stahl, W., & Sies, H. (2001). Effects of carotenoids and retinoids on gap junctional communication. Biofactors, 15(2‐4), 9598.Google Scholar
Stringham, J.M., Hammond, B.R., Nolan, J.M., Wooten, B.R., Mammen, A., Smollon, W., && Snodderly, D.M. (2008). The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration. Experimental Eye Research, 87(5), 445453.CrossRefGoogle ScholarPubMed
Teunissen, C.E., Van Boxtel, M.P.J., Bosma, H., Bosmans, E., Delanghe, J., De Bruijn, C., & De Vente, J. (2003). Inflammation markers in relation to cognition in a healthy aging population. Journal of Neuroimmunology, 134(1), 142150.Google Scholar
Trachtenberg, A.J., Filippini, N., Ebmeier, K.P., Smith, S.M., Karpe, F., & Mackay, C.E. (2012). The effects of APOE on the functional architecture of the resting brain. Neuroimage, 59(1), 565572.CrossRefGoogle ScholarPubMed
Vishwanathan, R., Iannaccone, A., Scott, T.M., Kritchevsky, S.B., Jennings, B.J., Carboni, G., & Johnson, E.J. (2014). Macular pigment optical density is related to cognitive function in older people. Age and Ageing, 43(2), 271275.Google Scholar
Vishwanathan, R., Kuchan, M., Sen, S., & Johnson, E. (2014). Lutein and preterm infants with decreased concentrations of brain carotenoids. Journal of Pediatric Gastroenterology and Nutrition, 59(5), 659665.Google Scholar
Vishwanathan, R., Neuringer, M., Snodderly, D.M., Schalch, W., & Johnson, E.J. (2013). Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates. Nutritional Neuroscience, 16(1), 2129.Google Scholar
Wechsler, D. (2001). Wechsler Test of Adult Reading: WTAR. San Antonio, TX: Psychological Corporation.Google Scholar
Wechsler, D. (2009). The Wechsler Memory Scale-Fourth Edition (WMS-IV). San Antonio, TX: Pearson Assessments.Google Scholar
Wang, W., Shinto, L., Connor, W.E., & Quinn, J.F. (2008). Nutritional biomarkers in Alzheimer’s disease: The association between carotenoids, n-3 fatty acids, and dementia severity. Journal of Alzheimer’s Disease, 13(1), 3138.Google Scholar
Witte, A.V., Kerti, L., Hermannstädter, H.M., Fiebach, J.B., Schreiber, S.J., Schuchardt, J.P., & Flöel, A. (2014). Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cerebral Cortex, 24(11), 30593068.Google Scholar
Xie, C., Bai, F., Yu, H., Shi, Y., Yuan, Y., Chen, G., & Li, S. (2012). Abnormal insula functional network is associated with episodic memory decline in amnestic mild cognitive impairment. Neuroimage, 63(1), 320327.Google Scholar
Yesavage, J.A., Brink, T.L., Rose, T.L., Lum, O., Huang, V., Adey, M., && Leirer, V.O. (1983). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 17(1), 3749.CrossRefGoogle Scholar
Figure 0

Fig. 1 Verbal Learning Task. The above figure provides a visual schematic of the progression of the verbal learning task. The four blocks (i.e., learning, control, retrieval, and fixation) were presented a total of 10 times, resulting in a total acquisition time of 12 min, 24 s. Five different words pairs were presented in each learning block and 5 sets of XXXXX – YYYYY pairings were presented in each control block. During each retrieval block, participants were asked to recall the second word for five different word pairs.

Figure 1

Table 1 Descriptive statistics (N=43)

Figure 2

Fig. 2 Panel (a) depicts whole-brain analyses of the encoding minus control contrast (independent of lutein and zeaxanthin levels) superimposed on a single-subject anatomical template in MNI space provided by MRIcron (http://www.mricro.com/mricron/install.html). To conserve space, only six slices were selected for visualization based on largest extent activation and thus not all voxel activity is represented. Panel (b) displays brain activation significantly related to lutein and zeaxanthin concentrations during encoding. Areas in green represent increased activation associated with lower MPOD levels, while areas in red represent increased activation associated with lower serum lutein and zeaxanthin. Only six slices were selected based on largest extent activation to showcase the relation of lutein and zeaxanthin to brain activity and thus not every significant cluster is displayed.

Figure 3

Fig. 3 Panel (a) depicts whole-brain analyses of the recall minus control contrast (independent of lutein and zeaxanthin levels) superimposed on a single-subject anatomical template in MNI space provided by MRIcron (http://www.mricro.com/mricron/install.html). To conserve space, only six slices were selected for visualization based on largest extent activation and thus not all significant voxel activity is represented. Panel (b) displays brain activation significantly related to lutein and zeaxanthin concentrations during retrieval. Areas in green represent increased activation associated with lower MPOD levels, while areas in red represent increased activation associated with lower serum lutein and zeaxanthin. Only six slices were selected based on largest extent activation to showcase the relation of lutein and zeaxanthin to brain activity and thus not every significant cluster is displayed.

Figure 4

Table 2 Relationship of lutein and zeaxanthin to brain activation during encoding (N=43)

Figure 5

Table 3 Relationship of lutein and zeaxanthin to brain activation during recall (N=43)